Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Trial
Phase 2
Withdrawn
March 1, 2022
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
Trial
Phase 2
Completed
March 1, 2022
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
Trial
Phase 3
Completed
March 1, 2022
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
Trial
Phase 3
Completed
March 1, 2022
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Trial
Phase 2
Terminated
Feb. 27, 2022
Cognitive-driven ADL Impairment as a Predictor for PDD
Trial
N/A
Completed
Feb. 23, 2022
Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing
Trial
N/A
Completed
Feb. 21, 2022
Compensation Mechanisms in Parkinson's Disease
Trial
N/A
Completed
Feb. 17, 2022
Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring
Trial
N/A
Completed
Feb. 17, 2022
Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
Trial
N/A
Not yet recruiting
Feb. 16, 2022
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.
Trial
Phase 3
Terminated
Feb. 15, 2022
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Trial
Phase 3
Terminated
Feb. 15, 2022
Incentive Spirometer and Inspiratory Muscle Trainer
Trial
N/A
Completed
Feb. 9, 2022
Spine MRI in Patients With Deep Brain Stimulation (DBS)
Trial
N/A
Completed
Feb. 8, 2022
DTI in Evaluation of Parkinsons Disease
Trial
N/A
Unknown
Feb. 8, 2022
Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
Trial
N/A
Terminated
Feb. 7, 2022
Multi-limb Dual-task Control in Parkinson's Disease
Trial
N/A
Completed
Feb. 6, 2022
Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease
Trial
N/A
Completed
Jan. 31, 2022
Movement Disorders and Early Maladaptive Schemas
Trial
N/A
Completed
Jan. 30, 2022
Effect of Immersive Virtual Reality Exergames in Patients With Parkinson's Disease
Trial
N/A
Completed
Jan. 27, 2022